Stratos Investment Management LLC Invests $216,000 in Lam Research Co. (NASDAQ:LRCX)

Stratos Investment Management LLC bought a new position in shares of Lam Research Co. (NASDAQ:LRCXFree Report) during the fourth quarter, Holdings Channel.com reports. The firm bought 2,992 shares of the semiconductor company’s stock, valued at approximately $216,000.

A number of other large investors also recently modified their holdings of LRCX. Stratos Wealth Partners LTD. acquired a new position in Lam Research in the fourth quarter valued at approximately $7,852,000. Yousif Capital Management LLC lifted its holdings in Lam Research by 816.7% in the fourth quarter. Yousif Capital Management LLC now owns 163,070 shares of the semiconductor company’s stock valued at $11,779,000 after buying an additional 145,281 shares during the period. Retirement Systems of Alabama lifted its holdings in Lam Research by 873.6% in the fourth quarter. Retirement Systems of Alabama now owns 278,579 shares of the semiconductor company’s stock valued at $20,122,000 after buying an additional 249,966 shares during the period. E. Ohman J or Asset Management AB acquired a new position in Lam Research in the fourth quarter valued at approximately $4,258,000. Finally, Mather Group LLC. lifted its holdings in Lam Research by 797.8% in the fourth quarter. Mather Group LLC. now owns 16,206 shares of the semiconductor company’s stock valued at $1,171,000 after buying an additional 14,401 shares during the period. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research Stock Performance

Shares of LRCX stock opened at $81.94 on Thursday. The stock has a market cap of $105.18 billion, a P/E ratio of 24.89, a P/E/G ratio of 1.34 and a beta of 1.46. The company has a debt-to-equity ratio of 0.51, a current ratio of 2.54 and a quick ratio of 1.73. The company has a fifty day moving average price of $76.32 and a two-hundred day moving average price of $78.33. Lam Research Co. has a one year low of $68.87 and a one year high of $113.00.

Lam Research (NASDAQ:LRCXGet Free Report) last announced its quarterly earnings results on Wednesday, January 29th. The semiconductor company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Lam Research had a net margin of 26.49% and a return on equity of 51.86%. As a group, equities analysts predict that Lam Research Co. will post 3.69 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts have commented on LRCX shares. Stifel Nicolaus reaffirmed a “buy” rating and issued a $100.00 target price (down previously from $105.00) on shares of Lam Research in a research note on Thursday, October 24th. Morgan Stanley upped their target price on shares of Lam Research from $76.00 to $78.00 and gave the company an “equal weight” rating in a research note on Thursday, December 5th. BNP Paribas raised shares of Lam Research to a “hold” rating in a research note on Thursday, October 24th. B. Riley lowered their target price on shares of Lam Research from $132.50 to $105.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Finally, StockNews.com downgraded shares of Lam Research from a “buy” rating to a “hold” rating in a research note on Friday, October 11th. Seven investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $95.72.

Read Our Latest Analysis on Lam Research

About Lam Research

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Featured Stories

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.